- ICH GCP
- US Clinical Trials Registry
- Search trials
Kliniske forsøg sponsoreret af Peking University Health Science Center Hospital
I alt 5953 resultater
-
Peking University Cancer Hospital & InstituteRekruttering
-
Peking University Cancer Hospital & InstituteIkke rekrutterer endnuKolorektal cancer | Radiofrekvensablation | Levermetastase | KRAS Gene | Sikker margin
-
Peking University Cancer Hospital & InstituteRekruttering
-
Peking University Cancer Hospital & InstituteRekruttering
-
Peking University Cancer Hospital & InstituteRekrutteringSlimhinde melanomKina
-
Peking University Cancer Hospital & InstituteRekruttering
-
Peking University Cancer Hospital & InstituteAktiv, ikke rekrutterende
-
Peking University Cancer Hospital & InstituteTilmelding efter invitationLokalt avanceret NSCLCKina
-
Peking University Cancer Hospital & InstituteAfsluttet
-
Peking University Cancer Hospital & InstituteAfsluttet
-
Peking University Cancer Hospital & InstituteUkendt
-
Peking University Cancer Hospital & InstituteUkendt
-
Peking University Cancer Hospital & InstituteUkendtEsophageal pladecellekarcinom | Mild dysplasi i spiserøret | Moderat dysplasi i spiserøret | Alvorlig dysplasi i spiserøret | Carcinoma in situ i spiserøretKina
-
Peking University Cancer Hospital & InstituteUkendt
-
Peking University Cancer Hospital & InstituteAfsluttetDifferentieret thyreoideacarcinom (DTC)
-
Peking University Cancer Hospital & InstituteUkendt
-
Peking University Cancer Hospital & InstituteUkendtMetastatisk nyrecellekarcinomKina
-
Peking University Cancer Hospital & InstituteUkendtNeoplasmer i leverenKina
-
Peking University Cancer Hospital & InstituteUkendt
-
Peking University Cancer Hospital & InstituteUkendtLymfom, stor B-celle, diffusKina
-
Peking University Cancer Hospital & InstituteUkendt
-
Peking University Cancer Hospital & InstituteAfsluttetNeoplasma i brystet | Lægemiddelterapi | Polymorfi, enkelt nukleotidKina
-
Peking University Cancer Hospital & InstituteAfsluttetBrystneoplasmer | Neoplasma MetastaseKina
-
Peking University Cancer Hospital & InstituteAfsluttetBrystneoplasmer | Neoplasma MetastaseKina
-
Peking University Cancer Hospital & InstituteUkendtUndersøgelse af små doser af etoposid som vedligeholdelsesbehandling ved småcellet lungekræft (SCLC)Småcellet lungekræft omfattende stadieKina
-
Peking University Cancer Hospital & InstituteUkendt
-
Peking University Cancer Hospital & InstituteRekrutteringIkke-operabelt hepatocellulært karcinomKina
-
Peking University Cancer Hospital & InstituteRekruttering
-
Peking University Cancer Hospital & InstituteRekruttering
-
Peking University Cancer Hospital & InstituteRekrutteringOvarie-, æggeleder- og primært peritonealt karcinomKina
-
Peking University Cancer Hospital & InstituteRekruttering
-
Peking University Cancer Hospital & InstituteRekruttering
-
Peking University Cancer Hospital & InstituteRekrutteringAvanceret malignt neoplasmaKina
-
Peking University Cancer Hospital & InstituteIkke rekrutterer endnu
-
Peking University Cancer Hospital & InstituteRekrutteringKolorektale levermetastaserKina
-
Peking University Cancer Hospital & InstituteRekrutteringAvanceret hepatocellulært karcinom (HCC)Kina
-
Peking University Cancer Hospital & InstituteRekrutteringMavekræft | Gastrisk AdenocarcinomKina
-
Peking University Cancer Hospital & InstituteRekruttering
-
Peking University Cancer Hospital & InstituteRekrutteringTyktarmskræft | Cirkulerende tumor-DNAKina
-
Peking University Cancer Hospital & InstituteRekruttering
-
Peking University Cancer Hospital & InstituteRekruttering
-
Peking University Cancer Hospital & InstituteIkke rekrutterer endnuPositron-emissionstomografi
-
Peking University Cancer Hospital & InstituteRekruttering
-
Peking University Cancer Hospital & InstituteRekrutteringHER2-positiv metastatisk brystkræft | Tidligere behandlet med Trastuzumab | Trastuzumab kombineret med Pertuzumab og kemoterapiKina
-
Peking University Cancer Hospital & InstituteRekruttering
-
Peking University Cancer Hospital & InstituteIkke rekrutterer endnu
-
Peking University Cancer Hospital & InstituteRekruttering
-
Peking University Cancer Hospital & InstituteRekrutteringHER2 positive eller mistænkelige positive tumorerKina
-
Peking University Cancer Hospital & InstituteRekrutteringGastrisk AdenocarcinomKina
-
Peking University Cancer Hospital & InstituteAfsluttetKolorektal cancer | Kirurgi | Levermetastaser | Minimal resterende sygdom | Cirkulerende tumor-DNAKina